Answers are grounded in this paper and cite their sources.
Use of a syringe shield to minimize the radiation dose to nuclear medicine technologists from 99mTc during kit preparation and patient injection is considered an integral part of an ALARA program. This paper discusses various parameters which should be taken into account in the design of a shield, and evaluates the efficacy of one in-house fabricated and two commercially available shields.
No takes yet. Share an insight, caveat, or question.
Norman L. McElroy (1981) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: